AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36123102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33105889 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH‐IT (Competent Adulthood Transition with Cognitive‐behavioral, Humanistic, and Interpersonal Training)
Number of subjects: 0
Study 33105889 — intervention group
Group type: COMPARATOR
Intervention: Online health education (HE)
Number of subjects: 0
Study 35943804 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham-controlled surgical intervention
Number of subjects: 1
Study 35943804 — intervention group
Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 1
Study 34391532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.2 mg
Number of subjects: 180
Study 34391532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.1 mg
Number of subjects: 180
Study 34391532 — intervention group
Group type: COMPARATOR
Intervention: Laser therapy
Number of subjects: 180
Study 33176727 — intervention group
Group type: EXPERIMENTAL
Intervention: Female treatment and concurrent male partner treatment (7 days of combined antibiotics - oral metronidazole 400 mg BID and 2% clindamycin cream applied topically to the glans penis and upper shaft BID)
Number of subjects: 342
Study 33176727 — intervention group
Group type: COMPARATOR
Intervention: Current standard of care (female treatment only)
Number of subjects: 342
Study 34036237 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced intensity conditioning (RIC)
Number of subjects: 48
Study 34036237 — intervention group
Group type: EXPERIMENTAL
Intervention: Myeloablative conditioning (MAC)
Number of subjects: 48
Study 34036237 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing positive for mutations
Number of subjects: 48
Study 34036237 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing additional genes
Number of subjects: 48
Study 33593139 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified feed with 1% olive leaves extract
Number of subjects: 400
Study 33593139 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified feed with 1.5% olive leaves extract
Number of subjects: 400
Study 33593139 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified feed with 2% olive leaves extract
Number of subjects: 400
Study 33593139 — intervention group
Group type: COMPARATOR
Intervention: Control group diet without olive leaves extract
Number of subjects: 400
Study 34006237 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam Daabo interventions (refresher training for providers, counseling tool, supportive supervision, availability of contraceptive services 7 days a week, client appointment cards, invitation letters for partners)
Number of subjects: 555
Study 34006237 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 555
Study 32209963 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Group D)
Number of subjects: 30
Study 32209963 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 30
Study 35660501 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (24‐h fast, 3 non‐consecutive days per week) in mice
Number of subjects: 58
Study 35660501 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting (24‐h fast, 3 non‐consecutive days per week) in humans (IF70)
Number of subjects: 58
Study 35660501 — intervention group
Group type: COMPARATOR
Intervention: Control group (ad libitum feeding) in mice
Number of subjects: 58
Study 35660501 — intervention group
Group type: COMPARATOR
Intervention: Control group (IF100) in humans
Number of subjects: 58
Study 34154319 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam (C/T)
Number of subjects: 405
Study 34154319 — intervention group
Group type: COMPARATOR
Intervention: Aminoglycosides/colistin/combination
Number of subjects: 405
Study 32087836 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-based treatment engagement intervention (TE)
Number of subjects: 86
Study 32087836 — intervention group
Group type: COMPARATOR
Intervention: non-MI assessment and information control (CON)
Number of subjects: 86
Study 33196574 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention before and during surgery
Number of subjects: 165
Study 33196574 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 165
Study 33196574 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 165
Study 32147362 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib 18 mg
Number of subjects: 1594
Study 32147362 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib 6 mg
Number of subjects: 1594
Study 32147362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1594
Study 36246987 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing based on mobile platform
Number of subjects: 104
Study 36246987 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up nursing
Number of subjects: 104
Study 34959801 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg/day DHA
Number of subjects: 0
Study 34959801 — intervention group
Group type: COMPARATOR
Intervention: 200 mg/day DHA
Number of subjects: 0
Study 34128219 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-3M (cognitive-focused intervention)
Number of subjects: 37
Study 34128219 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 37
Study 33275134 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose trivalent influenza vaccine
Number of subjects: 5260
Study 33275134 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose quadrivalent influenza vaccine
Number of subjects: 5260
Study 34371978 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocarbohydrate (IC) preload with apple (A + 35R)
Number of subjects: 0
Study 34371978 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercarbohydrate (HC) preload with apple (A + 50R)
Number of subjects: 0
Study 34371978 — intervention group
Group type: EXPERIMENTAL
Intervention: All preload treatments (IC and HC)
Number of subjects: 0
Study 34371978 — intervention group
Group type: COMPARATOR
Intervention: Reference (W + 50R)
Number of subjects: 0
Study 32333168 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light therapy (BWLT) - 10,000 lx, active arm, twice-daily 1-hour sessions for 4 weeks
Number of subjects: 35
Study 32333168 — intervention group
Group type: COMPARATOR
Intervention: Dim red light therapy (DRLT) - < 300 lx, control arm, twice-daily 1-hour sessions for 4 weeks
Number of subjects: 35
Study 32333168 — intervention group
Group type: COMPARATOR
Intervention: Comparison between BWLT and DRLT
Number of subjects: 35
Study 32333168 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life metrics
Number of subjects: 35
Study 32574773 — intervention group
Group type: EXPERIMENTAL
Intervention: AKB-9778 treatment
Number of subjects: 73
Study 32574773 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline metrics (FAZ area, presence of IRMA, peripapillary VD)
Number of subjects: 73
Study 37061370 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (0.5 mL) HPV vaccine
Number of subjects: 160
Study 37061370 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose (1.0 mL) HPV vaccine
Number of subjects: 160
Study 37061370 — intervention group
Group type: COMPARATOR
Intervention: Placebo (aluminum adjuvant)
Number of subjects: 160
Study 33388129 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 0
Study 33388129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33297622 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 19546
Study 33297622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test (FIT)
Number of subjects: 19546
Study 33297622 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel risk-adapted screening approach
Number of subjects: 19546
Study 33297622 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel risk-adapted screening approach (high-risk participants)
Number of subjects: 19546
Study 33297622 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel risk-adapted screening approach (low-risk participants)
Number of subjects: 19546
Study 35290446 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic daylight (DDL) condition
Number of subjects: 17
Study 35290446 — intervention group
Group type: COMPARATOR
Intervention: Habitual light (HL) condition
Number of subjects: 17
Study 33435904 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin (300 mg bd)
Number of subjects: 0
Study 33435904 — intervention group
Group type: COMPARATOR
Intervention: Ursodeoxycholic acid (up to 2000 mg daily)
Number of subjects: 0
Study 36334013 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 400
Study 36334013 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 400
Study 34086541 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors including depressed mood, availability of illegal drugs, sensation-seeking behavior, social learning, peer's drug use
Number of subjects: 8079
Study 34086541 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective factor: positive outlook of the future
Number of subjects: 8079
Study 34916649 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT with guided tissue regeneration (GTR)
Number of subjects: 120
Study 34916649 — intervention group
Group type: COMPARATOR
Intervention: RCT without guided tissue regeneration (GTR)
Number of subjects: 120
Study 34916649 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT with mineral trioxide aggregate (MTA) obturation
Number of subjects: 120
Study 34916649 — intervention group
Group type: EXPERIMENTAL
Intervention: RCT with gutta percha (GP) obturation
Number of subjects: 120
Study 35068204 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient actor training
Number of subjects: 0
Study 33316199 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes Toward LGBT People Scale
Number of subjects: 1007
Study 33316199 — intervention group
Group type: EXPERIMENTAL
Intervention: Religiosity
Number of subjects: 1007
Study 33316199 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisgender female students
Number of subjects: 1007
Study 35313763 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-sampling
Number of subjects: 12572
Study 35313763 — intervention group
Group type: COMPARATOR
Intervention: Reminder for Pap test
Number of subjects: 12572
Study 33183504 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter bariatric embolotherapy (TBE) targeting the left gastric artery using an occlusion balloon microcatheter to administer 300- to 500-μm embolic beads; patients also entered a lifestyle counseling program.
Number of subjects: 44
Study 33183504 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure; patients also entered a lifestyle counseling program.
Number of subjects: 44
Study 34756492 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential-CT-benefit-ANN model
Number of subjects: 0
Study 34756492 — intervention group
Group type: COMPARATOR
Intervention: Eighth AJCC staging system
Number of subjects: 0
Study 36414931 — intervention group
Group type: EXPERIMENTAL
Intervention: WebQuit
Number of subjects: 316
Study 36414931 — intervention group
Group type: COMPARATOR
Intervention: Smokefree
Number of subjects: 316
Study 34364011 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based high-intensity respiratory muscle training
Number of subjects: 0
Study 34364011 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study 32530368 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressor condition
Number of subjects: 130
Study 32530368 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 130
Study 35417762 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Plus Fluciclovine (18F) PET (arm 2)
Number of subjects: 165
Study 33764818 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 33764818 — intervention group
Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 0
Study 32302205 — intervention group
Group type: EXPERIMENTAL
Intervention: PLLA-HA screw
Number of subjects: 40
Study 32302205 — intervention group
Group type: COMPARATOR
Intervention: Titanium screw
Number of subjects: 40
Study 35918788 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml levobupivacaine 0.25%
Number of subjects: 48
Study 35918788 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml levobupivacaine 0.25%
Number of subjects: 48
Study 34369699 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion combined with pelvic floor muscle function training
Number of subjects: 150
Study 34369699 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle function training
Number of subjects: 150
Study 36792254 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 1858
Study 36792254 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1858
Study 36792254 — intervention group
Group type: EXPERIMENTAL
Intervention: MAE (both PCI and CABG)
Number of subjects: 1858
Study 36792254 — intervention group
Group type: EXPERIMENTAL
Intervention: Major or minor bleeding with blood transfusion ≥2 U (both PCI and CABG)
Number of subjects: 1858
Study 36792254 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke, unplanned revascularization for ischemia, renal failure (CABG only)
Number of subjects: 1858
Study 33235284 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral pharmacology (alcohol administration)
Number of subjects: 118
Study 33235284 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications that reduced stimulation, sedation, and craving during alcohol administration
Number of subjects: 118
Study 33235284 — intervention group
Group type: EXPERIMENTAL
Intervention: Leave-one-out Monte Carlo analysis
Number of subjects: 118
Study 32997422 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment seekers
Number of subjects: 240
Study 35832097 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Performance Coaching (OPC) and Four-Quadrant Model of Facilitated Learning (4QM) interventions
Number of subjects: 6
Study 33032975 — intervention group
Group type: EXPERIMENTAL
Intervention: Age quartile groups (0-3.3 years median interval between CCTA)
Number of subjects: 1153
Study 33032975 — intervention group
Group type: COMPARATOR
Intervention: Lowest age quartile group
Number of subjects: 1153
Study 35191412 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT-short
Number of subjects: 20
Study 35191412 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT-long
Number of subjects: 20
Study 35191412 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 20
Study 33770195 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise training for 12 weeks
Number of subjects: 35
Study 33770195 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 35
Study 32437690 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS) at 2 mA for 20 minutes, 3 times per week for 4 weeks (12 sessions)
Number of subjects: 45
Study 32437690 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation (control group)
Number of subjects: 45
Study 36100520 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injection of platelet-rich plasma
Number of subjects: 0
Study 36100520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33583066 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline (NS)
Number of subjects: 99
Study 33583066 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.025 ug/kg/min (NE25)
Number of subjects: 99
Study 33583066 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.05 ug/kg/min (NE50)
Number of subjects: 99
Study 33583066 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.075 ug/kg/min (NE75)
Number of subjects: 99
Study 33583066 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine 0.1 ug/kg/min (NE100)
Number of subjects: 99
Study 33583066 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine (all doses)
Number of subjects: 99
Study 33583066 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 99
Study 33583066 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine and NS
Number of subjects: 99
Study 32671996 — intervention group
Group type: EXPERIMENTAL
Intervention: PROACTIVE intervention (psycho-educational support)
Number of subjects: 13
Study 32671996 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 13
Study 34314831 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric hand exercise training (ISM) at 30% maximum voluntary contraction (MVC) for 10 weeks
Number of subjects: 50
Study 34314831 — intervention group
Group type: COMPARATOR
Intervention: Isotonic hand exercise training (IST) at 30% maximum voluntary contraction (MVC) for 10 weeks
Number of subjects: 50
Study 34099186 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (15 mg, oral)
Number of subjects: 20
Study 34099186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35325622 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldafermin 0.3 mg
Number of subjects: 171
Study 35325622 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldafermin 1.0 mg
Number of subjects: 171
Study 35325622 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldafermin 3.0 mg
Number of subjects: 171
Study 35325622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 32898998 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational Emotive Occupational Health Coaching (REOHC), 2-hour sessions weekly for 12 weeks
Number of subjects: 87
Study 32898998 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (WLG)
Number of subjects: 87
Study 35142814 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom monitoring intervention (daily symptom reports displayed during oncology rounds)
Number of subjects: 321
Study 35142814 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom monitoring intervention
Number of subjects: 321
Study 35142814 — intervention group
Group type: COMPARATOR
Intervention: Usual care (symptom reports not displayed)
Number of subjects: 321
Study 35142814 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 321
Study 34413633 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone 0.25 mg/h (low-dose group)
Number of subjects: 140
Study 34413633 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone 0.5 mg/h (control group)
Number of subjects: 140
Study 32141306 — intervention group
Group type: EXPERIMENTAL
Intervention: Galvanic current electrotherapy with conservative treatment (anti-inflammatory, vasodilatory and analgesic drugs) for 7 weeks, 3 times/week (20 sessions total)
Number of subjects: 34
Study 32141306 — intervention group
Group type: EXPERIMENTAL
Intervention: Galvanic current electrotherapy with conservative treatment
Number of subjects: 34
Study 32141306 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (anti-inflammatory, vasodilatory and analgesic drugs)
Number of subjects: 34
Study 36326824 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose convalescent plasma (CCP)
Number of subjects: 105
Study 36326824 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cumulative amount of neutralizing antibodies (subgroup of CCP)
Number of subjects: 105
Study 36326824 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CCP)
Number of subjects: 105
Study 36326824 — intervention group
Group type: EXPERIMENTAL
Intervention: CCP
Number of subjects: 105
Study 35298469 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Problem Management Plus (gPM+)
Number of subjects: 410
Study 35298469 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 410
Study 32178235 — intervention group
Group type: EXPERIMENTAL
Intervention: Cascade-parallel LSTM-CRF
Number of subjects: 5408
Study 32178235 — intervention group
Group type: COMPARATOR
Intervention: Traditional machine learning algorithms (multilayer perception, logistic regression, decision tree)
Number of subjects: 5408
Study 35338353 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD)
Number of subjects: 0
Study 35338353 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 0
Study 36319597 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-hour time-restricted eating (TRE) (ad libitum 12 PM-8 PM)
Number of subjects: 255
Study 36319597 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily calorie restriction (Cal-R) (25% restriction daily)
Number of subjects: 255
Study 36319597 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 255
Study 32454921 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency waves (20 J, 3 MHz, 10 minutes duration) applied to the masticatory muscles.
Number of subjects: 40
Study 32454921 — intervention group
Group type: COMPARATOR
Intervention: Sonophoresis procedures (0.9 W/cm2, 80% duty factor, 10 minutes duration) applied to the masticatory muscles with 25% Voltaren gel.
Number of subjects: 40
Study 35845740 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia combined with epidural block (Group A)
Number of subjects: 40
Study 35845740 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anesthesia (Group B)
Number of subjects: 40
Study 34143668 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii™ (virtual rehabilitation)
Number of subjects: 35
Study 34143668 — intervention group
Group type: COMPARATOR
Intervention: Control (stretching exercises)
Number of subjects: 35
Study 34143668 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Wii™ and Control)
Number of subjects: 35
Study 33791673 — intervention group
Group type: COMPARATOR
Intervention: TransFORM Body Treatment with TriHex Technology (TFB)
Number of subjects: 10
Study 33791673 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerating Skin Nectar with TriHex Technology (RSN) + TransFORM Body Treatment with TriHex Technology (TFB)
Number of subjects: 10
Study 32360666 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone vaginal ring (PVR)
Number of subjects: 789